I agree that this site is using cookies. You can find further informations here.
X
Siu, Lillian
407  results:
Search for persons X
?
1

A Phase II, Open-Label, Randomized Trial of Durvalumab With..:

Hernando-Calvo, Alberto ; Han, Ming ; Ayodele, Olubukola...
Clinical Colorectal Cancer.  , 2024
Link: https://doi.org/10.1016/..
 
?
2

Transverse Colon Primary Tumor Location as a Biomarker in M..:

Solar Vasconcelos, Joao Paulo ; Chen, Nan ; Titmuss, Emma...
Clinical Cancer Research.  30 (2024)  6 - p. 1121-1130 , 2024
Link: https://doi.org/10.1158/..
 
?
3

Ezabenlimab (BI 754091), an anti-PD-1 antibody, in patients..:

Patel, Manish R. ; Johnson, Melissa ; Winer, Ira...
Cancer Immunology, Immunotherapy.  73 (2024)  5 - p. , 2024
Link: https://doi.org/10.1007/..
 
?
4

Early Changes in Tumor-Naive Cell-Free Methylomes and Fragm..:

Stutheit-Zhao, Eric Y. ; Sanz-Garcia, Enrique ; Liu, Zhihui (Amy)...
Cancer Discovery.  14 (2024)  6 - p. 1048-1063 , 2024
Link: https://doi.org/10.1158/..
 
?
5

Prospective manipulation of the gut microbiome with microbi..:

Oliva, Marc ; Heirali, Alya ; Watson, Geoffrey...
British Journal of Cancer.  130 (2024)  12 - p. 1936-1942 , 2024
Link: https://doi.org/10.1038/..
 
?
6

Pembrolizumab plus concurrent chemoradiotherapy versus plac..:

Machiels, Jean-Pascal ; Tao, Yungan ; Licitra, Lisa...
The Lancet Oncology.  25 (2024)  5 - p. 572-587 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Multimodal detection of molecular residual disease in high-..:

Sanz-Garcia, Enrique ; Zou, Jinfeng ; Avery, Lisa...
Cell Death & Differentiation.  31 (2024)  4 - p. 460-468 , 2024
Link: https://doi.org/10.1038/..
 
?
8

Impact on costs and outcomes of multi-gene panel testing fo..:

Hernando-Calvo, Alberto ; Nguyen, Paul ; Bedard, Philippe L....
eClinicalMedicine.  69 (2024)  - p. 102443 , 2024
Link: https://doi.org/10.1016/..
 
?
9

Circulating tumour DNA kinetics in recurrent/metastatic hea..:

Taylor, Kirsty ; Zou, Jinfeng ; Magalhaes, Marcos...
European Journal of Cancer.  188 (2023)  - p. 29-38 , 2023
Link: https://doi.org/10.1016/..
 
?
10

A phase 2, multicenter, open-label study of anti-LAG-3 iera..:

Lin, Chia-Chi ; Garralda, Elena ; Schöffski, Patrick...
OncoImmunology.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1080/..
 
?
11

Targeting Molecular Residual Disease Using Novel Technologi..:

, In: Critical Issues in Head and Neck Oncology,
Sanz-Garcia, Enrique ; Siu, Lillian L. - p. 305-314 , 2023
Link: https://doi.org/10.1007/..
 
?
12

Phase Ib/II Study of the Efficacy and Safety of Binimetinib..:

Van Cutsem, Eric ; Yaeger, Rona ; Delord, Jean-Pierre...
The Oncologist.  28 (2023)  12 - p. e1209-e1218 , 2023
Link: https://doi.org/10.1093/..
 
?
13

Antibody–drug conjugates: in search of partners of choice:

Fuentes-Antrás, Jesús ; Genta, Sofia ; Vijenthira, Abi.
Trends in Cancer.  9 (2023)  4 - p. 339-354 , 2023
Link: https://doi.org/10.1016/..
 
?
14

Tumor Mutational Burden as a Predictor of Survival with Dur..:

Wildsmith, Sophie ; Li, Weimin ; Wu, Song...
Clinical Cancer Research.  29 (2023)  11 - p. 2066-2074 , 2023
Link: https://doi.org/10.1158/..
 
?
15

Precision cancer medicine: Concepts, current practice, and ..:

Edsjö, Anders ; Holmquist, Louise ; Geoerger, Birgit...
Journal of Internal Medicine.  294 (2023)  4 - p. 455-481 , 2023
Link: https://doi.org/10.1111/..
 
1-15